To genotype CYP2C19, 2 mL of blood were collected from each subject. DNA was extracted from leukocytes using a commercially available kit (Third Wave Technologies, Madison, WI, USA). The genotyping of the mutated genes CYP2C19*2 and *3 was conducted using PCR (the restriction fragment length polymorphism method).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.